"10.1371_journal.pone.0131932","plos one","2015-07-21T00:00:00Z","Andrew F Shorr; Laura A Puzniak; Pinaki Biswas; Michael S Niederman","Pulmonary Critical Care; Washington Hospital Center, Washington, DC, United States of America; Infectious Diseases and Vaccines; Pfizer Inc, Collegeville, Pennsylvania, United States of America; Biostatistics, Pfizer Inc, Collegeville, Pennsylvania, United States of America; Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, New York, United States of America","Conceived and designed the experiments: AS LAP PB MSN. Performed the experiments: PB. Analyzed the data: AS LAP PB MSN. Contributed reagents/materials/analysis tools: AS LAP PB MSN. Wrote the paper: AS LAP PB MSN.","This study was sponsored by Pfizer Inc. AS and MSN. did not receive financial compensation in connection with the study. AS has served as a speaker, investigator, or consultant for: AZ, Astellas, Bayer, Cubist, Pfizer, Tetraphase, and Theravance. MSN has been a consultant to Pfizer, Theravance, Cubist and Sanofi Aventis and has received research support from Bayer and Cubist. LAP. was an employee of Pfizer, Inc. when this study was undertaken. PB is an employee and stockholder of Pfizer, Inc. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","07","Andrew F Shorr","AFS",4,TRUE,4,1,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
